Atacand Side Effects

Generic name: candesartan

Please note - some side effects for Atacand may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

Side Effects of Atacand - for the consumer

Atacand HCT

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Atacand HCT:

Back pain; diarrhea; dizziness; lightheadedness, especially when sitting up or standing; nausea; numbness or tingling of the skin; tiredness.

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; confusion; decrease in sexual ability; depression; drowsiness; fainting; fast or irregular heartbeat; fever, chills, or persistent sore throat; decreased urination; hoarseness; muscle pain, tenderness, or cramps; red, swollen, blistered, or peeling skin; restlessness; seizures; severe or persistent dry mouth; shortness of breath; swelling of the arms or legs; unusual bruising or bleeding; unusual thirst, tiredness, or weakness; vomiting; yellowing of the skin or eyes.

Atacand

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Atacand:

Back pain; dizziness; upper respiratory tract infection.

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; hoarseness); change in the amount of urine produced; chest pain; dark urine; difficulty swallowing; fast, slow, or irregular heartbeat; fever, chills, or persistent sore throat; muscle pain or cramps; severe or persistent stomach pain (with or without nausea or vomiting); symptoms of low blood pressure (eg, fainting, lightheadedness, severe dizziness); unusual bruising or bleeding; yellowing of the eyes or skin.

By body system

General side effects

In general, candesartan has been well tolerated in large, prospective, placebo-controlled clinical trials. Overall, the rates of withdrawal of therapy due to adverse events among treated versus placebo patients were 3.3% and 3.5%, respectively.

Nervous system side effects

Nervous system side effects have been reported the most frequently. These have included headache (3%) and dizziness. Fatigue, vertigo, and paresthesias have been reported in at least 0.5% of patients.

Cardiovascular side effects

Caution should be observed when initiating therapy in patients with heart failure. Patients with heart failure given candesartan commonly have some reduction in blood pressure. In the CHARM program, the incidence of hypotension leading to drug discontinuation in candesartan-treated patients was 4.1% compared with 2.0% in placebo-treated patients.

Cardiovascular side effects including peripheral edema and chest pain have been reported in 1% of patients and at rates similar to placebo. Myocardial infarction and angina pectoris have been reported rarely. Hypotension (18.8% vs. 9.8% in placebo), tachycardia (0.5%), and palpitations (0.5%) have been reported. Rare cases of angioedema have also been reported.

Respiratory side effects

Candesartan did not significantly affect pulmonary function, bronchial hyperreactivity, or cough in patients with asthma.

Respiratory side effects have included cough, but it has been less frequent with the use of candesartan or other angiotensin II antagonists (reported in approximately 1% of treated patients and placebo patients alike) than with angiotensin converting enzyme inhibitors. Bronchitis, coughing, sinusitis, pharyngitis, upper respiratory tract infection, and dyspnea have been reported in approximately 0.5% to 1.0% of patients. Upper respiratory tract infections have been reported among 6% of treated patients (compared with 4% placebo patients) in controlled clinical trials. These infections have included pharyngitis (2% vs. 1% of patients) and rhinitis (2% vs. 1% of patients). A cause-and-effect relationship is unlikely.

Gastrointestinal side effects

Gastrointestinal side effects including nausea, vomiting, abdominal pain, and diarrhea have been reported in at least 1% of patients and at rates similar to placebo. Dyspepsia and gastroenteritis have been reported in 0.5% of patients. Alteration of taste sensitivity has also been associated with candesartan use.

Musculoskeletal side effects

Musculoskeletal side effects have included back pain (3%), arthralgias (1%), and myalgias (0.5%). Rarely, rhabdomyolysis have been reported during postmarketing experience in patients receiving angiotensin II receptor blockers.

Endocrine side effects

Endocrinologic side effects have been reported rarely. These have included hyperuricemia, hyperglycemia, hypertriglyceridemia, and elevated plasma creatine phosphokinase in approximately 0.5% of patients.

Hematologic side effects

Hematologic side effects including epistaxis has been reported in 0.5% of patients. Neutropenia, leukopenia, and agranulocytosis have been reported rarely. A causal relationship has not been established.

Psychiatric side effects

Psychiatric side effects have been reported rarely. These have included anxiety, depression, and somnolence in approximately 0.5% of patients.

Dermatologic side effects

Dermatologic side effects have been reported rarely. These have included rash or increased sweating in approximately 0.5% of patients. Psoriasis development or exacerbation has been reported. Pruritus and urticaria have been reported in postmarketing experience.

Genitourinary side effects

Genitourinary side effects including hematuria has been reported in 0.5% of patients. A causal relationship has not been established.

Metabolic side effects

Metabolic side effects have rarely included increased creatine phosphokinase, hyperglycemia, hypertriglyceridemia, hyperuricemia, hyperkalemia, and hyponatremia.

Hepatic side effects

Hepatic side effects have included transient elevations of serum liver transaminases. At least one case of hepatotoxicity with icterus, hepatomegaly, and abnormal liver function tests has been reported.

Renal side effects

Renal side effects including renal impairment and renal failure have been reported during postmarketing experience.

Hypersensitivity side effects

Hypersensitivity side effects have been reported rarely. At least one case of acute nephritic syndrome with accompanying pruritic rash has been reported.

Other side effects

Other side effects including asthenia and fever have been reported in approximately 0.5% of patients.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.